Annual CAPEX
N/A
31 March 2024
Summary:
Acasti Pharma annual capital expenditures is not available.ACST CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Acasti Pharma quarterly capital expenditures is not available.ACST Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Acasti Pharma TTM capital expenditures is not available.ACST TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACST CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ACST CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Acasti Pharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | $69.00 K(-78.4%) | $0.00(0.0%) | $69.00 K(-29.6%) |
| Dec 2020 | - | $0.00(-100.0%) | $98.00 K(-72.2%) |
| Sept 2020 | - | $33.00 K(-8.3%) | $352.00 K(+4.8%) |
| June 2020 | - | $36.00 K(+24.1%) | $336.00 K(+5.3%) |
| Mar 2020 | $319.00 K(-40.3%) | $29.00 K(-88.6%) | $319.00 K(+10.2%) |
| Dec 2019 | - | $254.00 K(+1394.1%) | $289.50 K(+94.4%) |
| Sept 2019 | - | $17.00 K(-10.5%) | $148.90 K(-55.5%) |
| June 2019 | - | $19.00 K(-3900.0%) | $334.70 K(-37.3%) |
| Mar 2019 | $534.00 K(+51.6%) | -$500.00(-100.4%) | $533.90 K(-14.8%) |
| Dec 2018 | - | $113.40 K(-44.1%) | $626.70 K(+0.7%) |
| Sept 2018 | - | $202.80 K(-7.1%) | $622.60 K(+25.5%) |
| June 2018 | - | $218.20 K(+136.4%) | $496.00 K(+40.7%) |
| Mar 2018 | $352.30 K(-81.4%) | $92.30 K(-15.6%) | $352.40 K(+35.5%) |
| Dec 2017 | - | $109.30 K(+43.4%) | $260.10 K(-60.8%) |
| Sept 2017 | - | $76.20 K(+2.1%) | $663.10 K(-33.6%) |
| June 2017 | - | $74.60 K(-85.4%) | $998.70 K(-26.5%) |
| Mar 2017 | $1.89 M | - | - |
| Nov 2016 | - | $512.30 K(+24.4%) | $1.36 M(+44.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2016 | - | $411.80 K(+4.9%) | $939.60 K(+67.6%) |
| May 2016 | - | $392.60 K(+821.6%) | $560.60 K(+106.4%) |
| Feb 2016 | $271.60 K(+295.3%) | $42.60 K(-54.0%) | $271.60 K(+17.4%) |
| Nov 2015 | - | $92.60 K(+182.3%) | $231.40 K(+51.2%) |
| Aug 2015 | - | $32.80 K(-68.3%) | $153.00 K(-6.8%) |
| May 2015 | - | $103.60 K(+4216.7%) | $164.20 K(+139.0%) |
| Feb 2015 | $68.70 K(-48.6%) | $2400.00(-83.1%) | $68.70 K(-39.8%) |
| Nov 2014 | - | $14.20 K(-67.7%) | $114.20 K(-22.9%) |
| Aug 2014 | - | $44.00 K(+443.2%) | $148.10 K(+23.4%) |
| May 2014 | - | $8100.00(-83.1%) | $120.00 K(-10.2%) |
| Feb 2014 | $133.60 K(+32.7%) | $47.90 K(-0.4%) | $133.70 K(-19.7%) |
| Nov 2013 | - | $48.10 K(+202.5%) | $166.40 K(+26.5%) |
| Aug 2013 | - | $15.90 K(-27.1%) | $131.50 K(+7.3%) |
| May 2013 | - | $21.80 K(-73.0%) | $122.60 K(+21.6%) |
| Feb 2013 | $100.70 K(+366.2%) | $80.60 K(+510.6%) | $100.80 K(+399.0%) |
| Nov 2012 | - | $13.20 K(+88.6%) | $20.20 K(+188.6%) |
| Aug 2012 | - | $7000.00(-20.5%) | $7000.00(-20.5%) |
| Feb 2011 | $21.60 K | $8800.00 | $8800.00 |
FAQ
- What is the all time high annual CAPEX for Acasti Pharma?
- What is the all time high quarterly CAPEX for Acasti Pharma?
- What is the all time high TTM CAPEX for Acasti Pharma?
What is the all time high annual CAPEX for Acasti Pharma?
Acasti Pharma all-time high annual capital expenditures is $1.89 M
What is the all time high quarterly CAPEX for Acasti Pharma?
Acasti Pharma all-time high quarterly capital expenditures is $512.30 K
What is the all time high TTM CAPEX for Acasti Pharma?
Acasti Pharma all-time high TTM capital expenditures is $1.36 M